Publications

211.

MolBook UNIPI-Create, Manage, Analyze, and Share Your Chemical Data for Free. Galati S, Di Stefano M, Macchia M, Poli G, Tuccinardi T. J Chem Inf Model. 2023, 63(13):3977-3982.


210.

An in silico toolbox for the prediction of the potential pathogenic effects of missense mutations in the dimeric region of hRPE65. Poli G, Demontis GC, Sodi A, Saba A, Rizzo S, Macchia M, Tuccinardi T. J Enzyme Inhib Med Chem. 2023, 38(1):2162047.


209.

miRNA-203b-3p Induces Acute and Chronic Pruritus through 5-HTR2B and TRPV4. De Logu F, Maglie R, Titiz M, Poli G, Landini L, Marini M, Souza Monteiro de Araujo D, De Siena G, Montini M, Cabrini DA, Otuki MF, Pawloski PL, Antiga E, Tuccinardi T, Calixto JB, Geppetti P, Nassini R, André E. J Invest Dermatol. 2023, 143(1):142-153.e10.


208.

Resveratrol Analogues as Dual Inhibitors of Monoamine Oxidase B and Carbonic Anhydrase VII: A New Multi-Target Combination for Neurodegenerative Diseases? Carradori S, Fantacuzzi M, Ammazzalorso A, Angeli A, De Filippis B, Galati S, Petzer A, Petzer JP, Poli G, Tuccinardi T, Agamennone M, Supuran CT. Molecules. 2022, 27(22):7816.


207.

Historical perspective of tumor glycolysis: A century with Otto Warburg. Bononi G, Masoni S, Di Bussolo V, Tuccinardi T, Granchi C, Minutolo F. Semin Cancer Biol. 2022, 86(Pt 2):325-333.


206.

Sirtuin 1-Activating Compounds: Discovery of a Class of Thiazole-Based Derivatives. Bononi G, Citi V, Lapillo M, Martelli A, Poli G, Tuccinardi T, Granchi C, Testai L, Calderone V, Minutolo F. Molecules. 2022, 27(19):6535.


205.

Targeting Acute Myelogenous Leukemia Using Potent Human Dihydroorotate Dehydrogenase Inhibitors Based on the 2-Hydroxypyrazolo[1,5-a]pyridine Scaffold: SAR of the Aryloxyaryl Moiety. Sainas S, Giorgis M, Circosta P, Poli G, Alberti M, Passoni A, Gaidano V, Pippione AC, Vitale N, Bonanni D, Rolando B, Cignetti A, Ramondetti C, Lanno A, Ferraris DM, Canepa B, Buccinnà B, Piccinini M, Rizzi M, Saglio G, Al-Karadaghi S, Boschi D, Miggiano R, Tuccinardi T, Lolli ML. J Med Chem. 2022, 65(19):12701-12724.


204.

Machine Learning-Based Virtual Screening for the Identification of Cdk5 Inhibitors. Di Stefano M, Galati S, Ortore G, Caligiuri I, Rizzolio F, Ceni C, Bertini S, Bononi G, Granchi C, Macchia M, Poli G, Tuccinardi T. Int J Mol Sci. 2022, 23(18):10653.


203.

Dissecting the Activity of Catechins as Incomplete Aldose Reductase Differential Inhibitors through Kinetic and Computational Approaches. Balestri F, Poli G, Piazza L, Cappiello M, Moschini R, Signore G, Tuccinardi T, Mura U, Del Corso A. Biology. 2022, 11(9):1324.


202.

Novel Potent and Selective Agonists of the GPR55 Receptor Based on the 3-Benzylquinolin-2(1H)-One Scaffold. Ceni C, Benko MJ, Mohamed KA, Poli G, Di Stefano M, Tuccinardi T, Digiacomo M, Valoti M, Laprairie RB, Macchia M, Bertini S. Pharmaceuticals. 2022, 15(7):768.


201.

Growth performances, chemical composition, and microbiological loads of mealworm reared with brewery spent grains and bread leftovers. Mancini S, Fratini F, Provera I, Dovicchi J, Tuccinardi T, Minieri S, Papini RA, Forzan M, Paci G. Ital J An Sc. 2022, 21(1):1419-1429.


I commenti sono chiusi.